Polyglutamine expansion diseases: failing to deliver.

[1]  Mark R. Segal,et al.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.

[2]  L. Vécsei,et al.  Huntington’s disease: pathomechanism and therapeutic perspectives , 2004, Journal of Neural Transmission.

[3]  E. Seeberg,et al.  Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro , 2004, Molecular and Cellular Biology.

[4]  Fabrice P Cordelières,et al.  Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.

[5]  G. Pigino,et al.  A novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons , 2004, The EMBO journal.

[6]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[7]  J. Littleton,et al.  Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Xiao-Jiang Li,et al.  Huntingtin-protein interactions and the pathogenesis of Huntington's disease. , 2004, Trends in genetics : TIG.

[9]  Scott T. Brady,et al.  Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport , 2003, Neuron.

[10]  Richard G. Brusch,et al.  Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.

[11]  M. MacDonald,et al.  Neocortical neurons cultured from mice with expanded cag repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults , 2003, Neuroscience.

[12]  W. Welch,et al.  Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. , 2003, Human molecular genetics.

[13]  Mark P Mattson,et al.  Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport , 2003, The Journal of Neuroscience.

[14]  H. Zoghbi,et al.  Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1 , 2003, Cell.

[15]  Yasushi Hiraoka,et al.  Mutations in Dynein Link Motor Neuron Degeneration to Defects in Retrograde Transport , 2003, Science.

[16]  W. Strittmatter,et al.  In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. , 2003, Archives of biochemistry and biophysics.

[17]  Claudio Soto,et al.  Unfolding the role of protein misfolding in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.

[18]  H. Bock,et al.  Reelin-mediated Signaling Locally Regulates Protein Kinase B/Akt and Glycogen Synthase Kinase 3β* , 2002, The Journal of Biological Chemistry.

[19]  M. Pericak-Vance,et al.  A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). , 2002, American journal of human genetics.

[20]  D. Rubinsztein,et al.  Glycogen Synthase Kinase-3β Inhibitors Prevent Cellular Polyglutamine Toxicity Caused by the Huntington's Disease Mutation* , 2002, The Journal of Biological Chemistry.

[21]  H. Zoghbi,et al.  Mouse and fly models of neurodegeneration. , 2002, Trends in genetics : TIG.

[22]  F. Piccioni,et al.  Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motoneuronal processes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  G. Sobue,et al.  Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy , 2002, Neuron.

[24]  Christopher A Ross,et al.  Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders , 2002, Neuron.

[25]  M. Donelan,et al.  Ca2+-dependent dephosphorylation of kinesin heavy chain on beta-granules in pancreatic beta-cells. Implications for regulated beta-granule transport and insulin exocytosis. , 2002, The Journal of biological chemistry.

[26]  Fabrice P Cordelières,et al.  The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. , 2002, Developmental cell.

[27]  Nancy Ratner,et al.  Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin‐based motility , 2002, The EMBO journal.

[28]  S. Brady,et al.  Regulation of Kinesin: Implications for Neuronal Development , 2001, Developmental Neuroscience.

[29]  H Li,et al.  Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice , 2001, The Journal of Neuroscience.

[30]  H. Zoghbi,et al.  Altered trafficking of membrane proteins in purkinje cells of SCA1 transgenic mice. , 2001, The American journal of pathology.

[31]  N. Hirokawa,et al.  Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.

[32]  H. Orr,et al.  Beyond the Qs in the polyglutamine diseases. , 2001, Genes & development.

[33]  Elena Cattaneo,et al.  Loss of normal huntingtin function: new developments in Huntington's disease research , 2001, Trends in Neurosciences.

[34]  D. Rubinsztein,et al.  The molecular biology of Huntington's disease , 2001, Psychological Medicine.

[35]  M. MacDonald,et al.  Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. , 2000, Human molecular genetics.

[36]  L. Goldstein,et al.  Kinesin-Dependent Axonal Transport Is Mediated by the Sunday Driver (SYD) Protein , 2000, Cell.

[37]  H. Zoghbi,et al.  Identification of genes that modify ataxin-1-induced neurodegeneration , 2000, Nature.

[38]  Michael S. Levine,et al.  Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice , 2000, Nature Genetics.

[39]  James F. Gusella,et al.  Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease , 2000, Nature Reviews Neuroscience.

[40]  N. Weigel,et al.  Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. , 2000, Human molecular genetics.

[41]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[42]  M. Beal,et al.  Bioenergetics in Huntington's Disease , 1999, Annals of the New York Academy of Sciences.

[43]  W. Saxton,et al.  Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport. , 1999, Molecular biology of the cell.

[44]  I. Kanazawa,et al.  Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. , 1999, Human molecular genetics.

[45]  M. Beal,et al.  Oxidative Stress in Huntington's Disease , 1999, Brain pathology.

[46]  S. Tabrizi,et al.  Biochemical abnormalities and excitotoxicity in Huntington's disease brain , 1999, Annals of neurology.

[47]  Y. Liu.  Expression of Polyglutamine-expanded Huntingtin Activates the SEK1-JNK Pathway and Induces Apoptosis in a Hippocampal Neuronal Cell Line* , 1998, The Journal of Biological Chemistry.

[48]  Harry T Orr,et al.  Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.

[49]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[50]  G. Bloom,et al.  A Role for Cyclin-Dependent Kinase(s) in the Modulation of Fast Anterograde Axonal Transport: Effects Defined by Olomoucine and the APC Tumor Suppressor Protein , 1998, The Journal of Neuroscience.

[51]  S. Hersch,et al.  Interaction of Huntingtin-Associated Protein with Dynactin P150Glued , 1998, The Journal of Neuroscience.

[52]  N. Hirokawa,et al.  Kinesin and dynein superfamily proteins and the mechanism of organelle transport. , 1998, Science.

[53]  R. Albin,et al.  Ectopically Expressed CAG Repeats Cause Intranuclear Inclusions and a Progressive Late Onset Neurological Phenotype in the Mouse , 1997, Cell.

[54]  S. Brady,et al.  Direct effect of the neurotoxicant acrylamide on kinesin‐based microtubule motility , 1996, Journal of neuroscience research.

[55]  S. Brady,et al.  Biochemical and functional diversity of microtubule motors in the nervous system , 1995, Current Opinion in Neurobiology.

[56]  R. Carraway,et al.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.

[57]  P. Hollenbeck,et al.  Phosphorylation of Kinesin inVivo Correlates with Organelle Association and Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.

[58]  K S Kosik,et al.  Kinesin-mediated organelle translocation revealed by specific cellular manipulations , 1994, The Journal of cell biology.

[59]  P. J. Morin,et al.  Inhibition of kinesin synthesis and rapid anterograde axonal transport in vivo by an antisense oligonucleotide. , 1993, The Journal of biological chemistry.

[60]  J. Mendell,et al.  Studies on the pathogenesis of vincristine‐induced neuropathy , 1987, Muscle & nerve.

[61]  S. Brady.  Axonal Transport Methods and Applications , 1985 .